Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Autoimmune Disorders

  Free Subscription


1 Am J Kidney Dis
9 Diabet Med
3 Diabetes
7 Diabetes Res Clin Pract
1 Intern Med
2 J Autoimmun
7 J Clin Endocrinol Metab
2 J Neuroimmunol
4 J Neurol
2 Kidney Int
2 Lancet
3 Lancet Neurol
6 Mult Scler
2 N Engl J Med
1 Neurologia (Engl Ed)
1 Neurology
1 PLoS One
1 Thyroid

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Kidney Dis

  1. TANG C, Chen P, Si FL, Lv JC, et al
    Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
    PubMed         Abstract available

    Diabet Med

  2. MOSER O, Pemberton JS
    Rethinking the safety and efficacy assessment of (Hybrid) Closed Loop systems: Should we promote the need for a minimum of exercise data within the regulatory approval?
    Diabet Med. 2024;41:e15305.

  3. ZHOU Y, Sardana D, Kuroko S, Haszard JJ, et al
    Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomi
    Diabet Med. 2024 Jan 10:e15280. doi: 10.1111/dme.15280.
    PubMed         Abstract available

  4. WIBAEK R, Ibfelt EH, Andersen GS, Hulman A, et al
    Heterogeneity in glycaemic control in children and adolescents with type 1 diabetes: A latent class trajectory analysis of Danish nationwide data.
    Diabet Med. 2023 Dec 29:e15275. doi: 10.1111/dme.15275.
    PubMed         Abstract available

  5. GRAMMES J, Schmid S, Bozkurt L, Heinemann L, et al
    Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry.
    Diabet Med. 2023 Nov 27:e15261. doi: 10.1111/dme.15261.
    PubMed         Abstract available

  6. LEELARATHNA L, Sutton CJ, Evans ML, Neupane S, et al
    Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
    Diabet Med. 2023 Oct 28:e15249. doi: 10.1111/dme.15249.
    PubMed         Abstract available

  7. ELLIOTT RA, Rogers G, Evans ML, Neupane S, et al
    Estimating the cost effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
    Diabet Med. 2023 Sep 26:e15232. doi: 10.1111/dme.15232.
    PubMed         Abstract available

  8. KELLY RC, Holt RIG, Desborough L, Majidi S, et al
    The Psychosocial Burdens of Living with Diabetes.
    Diabet Med. 2023 Sep 3:e15219. doi: 10.1111/dme.15219.
    PubMed         Abstract available

  9. TANG TS, Yip AKW, Klein G, Moore L, et al
    Training peers to deliver mental health support to adults with Type 1 diabetes using the REACHOUT Mobile App.
    Diabet Med. 2023 Aug 27:e15210. doi: 10.1111/dme.15210.
    PubMed         Abstract available

  10. HENDRIECKX C, Husin HM, Russell-Green S, Halliday JA, et al
    The Diabetes Management Experiences Questionnaire: Psychometric validation among adults with type 1 diabetes.
    Diabet Med. 2023 Aug 10:e15195. doi: 10.1111/dme.15195.
    PubMed         Abstract available


  11. KASINATHAN D, Guo Z, Sarver DC, Wong GW, et al
    Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice.
    Diabetes. 2024 Feb 22:db230568. doi: 10.2337/db23-0568.
    PubMed         Abstract available

  12. KIM YK, Kim YR, Wells KL, Sarbaugh D, et al
    PTPN2 Regulates Metabolic Flux to Affect beta-Cell Susceptibility to Inflammatory Stress.
    Diabetes. 2024;73:434-447.
    PubMed         Abstract available

  13. KUGATHASAN L, Sridhar VS, Lovblom LE, Matta S, et al
    Interactive effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals with Type 1 Diabetes.
    Diabetes. 2023 Nov 28:db230694. doi: 10.2337/db23-0694.
    PubMed         Abstract available

    Diabetes Res Clin Pract

  14. STOCCO A, Trawley S, Kong YW, Yuan CY, et al
    "You can hide it if you want to, you can let it be seen if you want to": A qualitative study of the lived experiences of Australian adults with type 1 diabetes using the Omnipod DASH(R) system.
    Diabetes Res Clin Pract. 2024;208:111123.
    PubMed         Abstract available

  15. HOOD KK, Schneider-Utaka AK, Reed ZW, Buckingham BA, et al
    Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology.
    Diabetes Res Clin Pract. 2024;208:111114.
    PubMed         Abstract available

  16. AHOLA AJ, Tikkanen-Dolenc H, Harjutsalo V, Groop PH, et al
    Clustering of risk behaviours and associations between risk behaviours and cardio-metabolic risk factors in adult individuals with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111115.
    PubMed         Abstract available

  17. ALI L, Alhassan M
    Challenges in achieving adequate glycemic control among children with type 1 diabetes mellitus in a resource-limited setting: A cross-sectional study from Sudan.
    Diabetes Res Clin Pract. 2024;208:111113.
    PubMed         Abstract available

  18. BURKHARDT MS, Pirri C, Summers MA, Barrie P, et al
    Group-based behaviour therapy improves self-care, glycaemic control and distress in adults with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111095.
    PubMed         Abstract available

  19. NEUMAN V, Vavra D, Drnkova L, Pruhova S, et al
    Introduction of continuous glucose monitoring (CGM) is a key factor in decreasing HbA1c in war refugee children with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111118.
    PubMed         Abstract available

  20. ZHANG P, Zhang Z, Zhong J, Zheng X, et al
    Cardiovascular diseases consequences of type 1, type 2 diabetes mellitus and glycemic traits: A Mendelian randomization study.
    Diabetes Res Clin Pract. 2024;208:111094.
    PubMed         Abstract available

    Intern Med

  21. SUMICHIKA Y, Temmoku J, Saito K, Yoshida S, et al
    New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review.
    Intern Med. 2024 Feb 19. doi: 10.2169/internalmedicine.3211.
    PubMed         Abstract available

    J Autoimmun

  22. VERGOUWEN DPC, van Beek AA, de Hoog J, de Boer JH, et al
    The enigma of sclera-specific autoimmunity in scleritis.
    J Autoimmun. 2024;144:103178.
    PubMed         Abstract available

  23. HOXHA A, Perin N, Lovisotto M, Calligaro A, et al
    Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
    J Autoimmun. 2024;144:103180.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  24. WU Q, Zhou J, Fang W, Jiang WH, et al
    Structural and functional brain changes after glucocorticoid therapy in thyroid-associated ophthalmopathy.
    J Clin Endocrinol Metab. 2023 Oct 21:dgad626. doi: 10.1210.
    PubMed         Abstract available

  25. KIM KM, Kim KJ, Han K, Rhee Y, et al
    Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2024;109:e1194-e1203.
    PubMed         Abstract available

  26. LUI DTW, Wong CKH, Man KKC
    Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad614. doi: 10.1210.

  27. MULLER I, Consonni D, Crivicich E, di Marco F, et al
    Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad616. doi: 10.1210.

  28. MENON JC, Singh P, Archana A, Singh P, et al
    High frequency of recessive WFS1 mutations among Indian children with islet antibody-negative type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Nov 1:dgad644. doi: 10.1210.
    PubMed         Abstract available

  29. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    PubMed         Abstract available

  30. FU J, Guan H
    The Impact of Salt Iodization on the Occurrence of Hyperthyroidism: Evidence from General Populations to Pregnant Women.
    J Clin Endocrinol Metab. 2023 Aug 31:dgad522. doi: 10.1210.

    J Neuroimmunol

  31. GALETTA K, Ham AS, Vishnevetsky A, Bhattacharyya S, et al
    Disease modifying therapy in the treatment of tumefactive multiple sclerosis: A retrospective cohort study.
    J Neuroimmunol. 2024;388:578299.
    PubMed         Abstract available

  32. LI X, Chen JJ, Hur M, Paton GR, et al
    Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype.
    J Neuroimmunol. 2024;388:578312.
    PubMed         Abstract available

    J Neurol

  33. OHNARI K, Hashimoto T, Iwanaka Y, Ohnari K, et al
    Dramatic improvement in refractory myasthenia gravis with eculizumab treatment: a case report.
    J Neurol. 2024 Feb 23. doi: 10.1007/s00415-024-12245.

  34. GREGULETZ P, Plotz M, Baade-Buttner C, Bien CG, et al
    Different pain phenotypes are associated with anti-Caspr2 autoantibodies.
    J Neurol. 2024 Feb 22. doi: 10.1007/s00415-024-12224.
    PubMed         Abstract available

  35. CUTILLO G, Rubin M, d'Amore G, Malcangi M, et al
    Infratentorial posterior reversible encephalopathy syndrome in INFbeta1a-treated multiple sclerosis patient.
    J Neurol. 2024 Feb 22. doi: 10.1007/s00415-024-12226.

  36. BIANCHI A, Matranga D, Patti F, Maniscalco L, et al
    The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT).
    J Neurol. 2024 Feb 16. doi: 10.1007/s00415-024-12214.
    PubMed         Abstract available

    Kidney Int

  37. WANG H, Zuiani J, Coates Ao PT, Xia Y, et al
    Reconstructing the interface between the human intestine and immune system: potential to advance mechanistic studies in IgA nephropathy.
    Kidney Int. 2024;105:423-426.

  38. VOINESCU CD, Mozere M, Genovese G, Downie ML, et al
    A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy.
    Kidney Int. 2024 Feb 14:S0085-2538(24)00073-5. doi: 10.1016/j.kint.2024.
    PubMed         Abstract available


  39. KRONBICHLER A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, et al
    Diagnosis and management of ANCA-associated vasculitis.
    Lancet. 2024;403:683-698.
    PubMed         Abstract available

    Abatacept in individuals with autoantibody-positive arthralgia at risk for rheumatoid arthritis.
    Lancet. 2024 Feb 14:S0140-6736(24)00055-2. doi: 10.1016/S0140-6736(24)00055.

    Lancet Neurol

  41. RAMDAS S, Palace J
    PROMISE of low-cost immunosuppressants for myasthenia gravis.
    Lancet Neurol. 2024;23:223-225.

  42. NARAYANASWAMI P, Sanders DB, Thomas L, Thibault D, et al
    Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.
    Lancet Neurol. 2024;23:267-276.
    PubMed         Abstract available

  43. CHATAWAY J, Williams T, Li V, Marrie RA, et al
    Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges.
    Lancet Neurol. 2024;23:277-301.
    PubMed         Abstract available

    Mult Scler

  44. BOAVENTURA M, Sastre-Garriga J, Rimkus CM, Rovira A, et al
    T1/T2-weighted ratio: A feasible MRI biomarker in multiple sclerosis.
    Mult Scler. 2024 Feb 22:13524585241233448. doi: 10.1177/13524585241233448.
    PubMed         Abstract available

  45. EMMA C, Vesela P, Kay P, Huseyin H, et al
    Psoriasiform dermatitis following ocrelizumab in relapsing-remitting multiple sclerosis: Case report and literature review.
    Mult Scler. 2024 Feb 22:13524585241232277. doi: 10.1177/13524585241232277.
    PubMed         Abstract available

  46. ERCAN MB, Kocer B, Altiparmak T, Arslan I, et al
    Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis.
    Mult Scler. 2024 Feb 22:13524585241231655. doi: 10.1177/13524585241231655.

  47. JALALEDDINI K, Bermel RA, Talente B, Weinstein D, et al
    A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis.
    Mult Scler. 2024 Feb 19:13524585241227372. doi: 10.1177/13524585241227372.
    PubMed         Abstract available

  48. ROCCA MA, D'Amore G, Valsasina P, Tedone N, et al
    2.5-Year changes of connectivity dynamism are relevant for physical and cognitive deterioration in multiple sclerosis.
    Mult Scler. 2024 Feb 19:13524585241231155. doi: 10.1177/13524585241231155.
    PubMed         Abstract available

  49. ROVARIS M, Toselli E, Mendozzi L, Di Tella S, et al
    Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study.
    Mult Scler. 2024 Feb 19:13524585241230236. doi: 10.1177/13524585241230236.
    PubMed         Abstract available

    N Engl J Med

  50. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    PubMed         Abstract available

    CAR T Cells - A New Horizon for Autoimmunity?
    N Engl J Med. 2024;390:758-759.

    Neurologia (Engl Ed)

  52. GARCIA ESTEVEZ DA, Pinal Osorio I, Pato Pato A
    Alemtuzumab and autoimmune polyglandular syndrome with type 1 diabetes mellitus.
    Neurologia (Engl Ed). 2024 Feb 20:S2173-5808(24)00044.


  53. YOUNG A, Johnston JL
    Pearls & Oy-sters: Ocular Myasthenia Gravis: Central Ocular Motor Signs and Unilateral Visual Loss Caused by the Great Neuro-Ophthalmologic Impersonator.
    Neurology. 2024;102:e209260.
    PubMed         Abstract available

    PLoS One

  54. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    PubMed         Abstract available


    Reassessing Selenium for the Management of Hashimoto's Thyroiditis: the Selini* shines bright for AIT patients.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2024.0078.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.